84 related articles for article (PubMed ID: 2899457)
1. Contrasting actions of staurosporine, a protein kinase C inhibitor, on human neutrophils and primary mouse epidermal cells.
Sako T; Tauber AI; Jeng AY; Yuspa SH; Blumberg PM
Cancer Res; 1988 Aug; 48(16):4646-50. PubMed ID: 2899457
[TBL] [Abstract][Full Text] [Related]
2. Partial parallelism and partial blockade by bryostatin 1 of effects of phorbol ester tumor promoters on primary mouse epidermal cells.
Sako T; Yuspa SH; Herald CL; Pettit GR; Blumberg PM
Cancer Res; 1987 Oct; 47(20):5445-50. PubMed ID: 2888531
[TBL] [Abstract][Full Text] [Related]
3. Staurosporine induces protein kinase C agonist effects and maturation of normal and neoplastic mouse keratinocytes in vitro.
Dlugosz AA; Yuspa SH
Cancer Res; 1991 Sep; 51(17):4677-84. PubMed ID: 1678684
[TBL] [Abstract][Full Text] [Related]
4. Similar effects of phospholipase C and phorbol ester tumor promoters on primary mouse epidermal cells.
Jeng AY; Lichti U; Strickland JE; Blumberg PM
Cancer Res; 1985 Nov; 45(11 Pt 2):5714-21. PubMed ID: 3931907
[TBL] [Abstract][Full Text] [Related]
5. H-7, a protein kinase C inhibitor, inhibits phorbol ester-caused ornithine decarboxylase induction but fails to inhibit phorbol ester-caused suppression of epidermal growth factor binding in primary cultured mouse epidermal cells.
Nakadate T; Yamamoto S; Aizu E; Nishikawa K; Kato R
Mol Pharmacol; 1989 Dec; 36(6):917-24. PubMed ID: 2601687
[TBL] [Abstract][Full Text] [Related]
6. Tumor-promoting activity of staurosporine, a protein kinase inhibitor on mouse skin.
Yoshizawa S; Fujiki H; Suguri H; Suganuma M; Nakayasu M; Matsushima R; Sugimura T
Cancer Res; 1990 Aug; 50(16):4974-8. PubMed ID: 2165851
[TBL] [Abstract][Full Text] [Related]
7. Protein kinase inhibitor, staurosporine, induces a mature neuronal phenotype in SH-SY5Y human neuroblastoma cells through an alpha-, beta-, and zeta-protein kinase C-independent pathway.
Jalava A; Akerman K; Heikkilä J
J Cell Physiol; 1993 May; 155(2):301-12. PubMed ID: 8482723
[TBL] [Abstract][Full Text] [Related]
8. Modulation of 1-[beta-D-arabinofuranosyl] cytosine-induced apoptosis in human myeloid leukemia cells by staurosporine and other pharmacological inhibitors of protein kinase C.
Grant S; Turner AJ; Bartimole TM; Nelms PA; Joe VC; Jarvis WD
Oncol Res; 1994; 6(2):87-99. PubMed ID: 7949469
[TBL] [Abstract][Full Text] [Related]
9. Differential inhibition of the epidermal growth factor-, platelet-derived growth factor-, and protein kinase C-mediated signal transduction pathways by the staurosporine derivative CGP 41251.
Andrejauskas-Buchdunger E; Regenass U
Cancer Res; 1992 Oct; 52(19):5353-8. PubMed ID: 1394140
[TBL] [Abstract][Full Text] [Related]
10. The erbstatin analogue methyl 2,5-dihydroxycinnamate cross-links proteins and is cytotoxic to normal and neoplastic epithelial cells by a mechanism independent of tyrosine kinase inhibition.
Stanwell C; Burke TR; Yuspa SH
Cancer Res; 1995 Nov; 55(21):4950-6. PubMed ID: 7585535
[TBL] [Abstract][Full Text] [Related]
11. Specific binding to protein kinase C by ingenol and its induction of biological responses.
Hasler CM; Acs G; Blumberg PM
Cancer Res; 1992 Jan; 52(1):202-8. PubMed ID: 1727380
[TBL] [Abstract][Full Text] [Related]
12. Involvement of protein kinase C activation in ornithine decarboxylase gene expression in primary culture of newborn mouse epidermal cells and in skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate.
Verma AK; Pong RC; Erickson D
Cancer Res; 1986 Dec; 46(12 Pt 1):6149-55. PubMed ID: 3779635
[TBL] [Abstract][Full Text] [Related]
13. Initiator and promoter induced specific changes in epidermal function and biological potential.
Yuspa SH; Hennings H; Lichti U
J Supramol Struct Cell Biochem; 1981; 17(3):245-57. PubMed ID: 7328673
[TBL] [Abstract][Full Text] [Related]
14. Regulation of epidermal transglutaminase activity and terminal differentiation by retinoids and phorbol esters.
Yuspa SH; Ben T; Lichti U
Cancer Res; 1983 Dec; 43(12 Pt 1):5707-12. PubMed ID: 6139162
[TBL] [Abstract][Full Text] [Related]
15. Contrasting duration of inhibition of cell-cell communication in primary mouse epidermal cells by phorbol 12,13-dibutyrate and by bryostatin 1.
Pasti G; Rivedal E; Yuspa SH; Herald CL; Pettit GR; Blumberg PM
Cancer Res; 1988 Jan; 48(2):447-51. PubMed ID: 3422054
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of bryostatins and phorbol esters on arachidonic acid metabolite release and epidermal growth factor binding in C3H 10T1/2 cells.
Dell'Aquila ML; Herald CL; Kamano Y; Pettit GR; Blumberg PM
Cancer Res; 1988 Jul; 48(13):3702-8. PubMed ID: 3132318
[TBL] [Abstract][Full Text] [Related]
17. Protein kinase C-dependent and -independent pathways mediate epidermal growth factor (EGF) effects in human endometrial adenocarcinoma cell line KLE.
Gretz HF; Talavera F; Connor P; Pearl M; Lelle RJ; Roberts JA; Menon KM
Gynecol Oncol; 1994 May; 53(2):228-33. PubMed ID: 8188084
[TBL] [Abstract][Full Text] [Related]
18. Staurosporine, a potent protein kinase C inhibitor, fails to inhibit 12-O-tetradecanoylphorbol-13-acetate-caused ornithine decarboxylase induction in isolated mouse epidermal cells.
Kiyoto I; Yamamoto S; Aizu E; Kato R
Biochem Biophys Res Commun; 1987 Oct; 148(2):740-6. PubMed ID: 3689369
[TBL] [Abstract][Full Text] [Related]
19. Activation of erbB2 and c-src in phorbol ester-treated mouse epidermis: possible role in mouse skin tumor promotion.
Xian W; Rosenberg MP; DiGiovanni J
Oncogene; 1997 Mar; 14(12):1435-44. PubMed ID: 9136987
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of tumor promoter 12-O-tetradecanoylphorbol-13-acetate-induced synthesis of epidermal ornithine decarboxylase messenger RNA and diacylglycerol-promoted mouse skin tumor formation by retinoic acid.
Verma AK
Cancer Res; 1988 Apr; 48(8):2168-73. PubMed ID: 3349487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
